HSA — authorised 1 July 2009
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: likely_approved
HSA authorised Multaq on 1 July 2009
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 1 July 2009.
SANOFI AVENTIS US holds the Singaporean marketing authorisation.